Publications by authors named "Marc-Eric Halatsch"

Claim this Profile
A
Assessment of Photodynamic Therapy Penetration Depth in a Synthetic Pig Brain Model: A Novel Approach to Simulate the Reach of PDT-Mediated Effects In Vitro.
Nicolas Bader, Annika Hajosch, Christian Peschmann, Kathrin Stucke-Straub, Christian Rainer Wirtz, Marc-Eric Halatsch

Pharmaceuticals (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranioplasty complications in severe traumatic brain injury: implications of timing of surgery, implant material and incidence of vetriculomegaly versus Post-Traumatic hydrocephalus.
Salvatore Chibbaro, Ismail Zaed, Guillaume Dannhoff, Julien Todeschi, Charles-Henry Mallereau, Marc-Eric Halatsch

Neurosurg Rev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMILE-stereotactic multiple fraction radiotherapy for non-spine bone metastases: study protocol for a multicenter, open-label phase III randomized controlled trial.
Robert Foerster, Daniel R Zwahlen, Christina Schroeder, Paul Windisch, Marc-Eric Halatsch

Trials· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Qiyu Cao, Annika Hajosch, Richard Eric Kast, Christopher Loehmann, Michal Hlavac, Marc-Eric Halatsch

Br J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma.
Nicolas Bader, Christian Peschmann, Richard Eric Kast, Tim Heiland, Tamara Merz, Marc-Eric Halatsch

Photodiagnosis Photodyn Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.
Marc-Eric Halatsch

Biomedicines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of reduced operating room capacity on the time delay of urgent surgical care for neurosurgical patients during the COVID-19 pandemic.
Daniel Schöni, Marc-Eric Halatsch, Alex Alfieri

Interdiscip Neurosurg· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.
Richard E Kast, Alex Alfieri, Hazem I Assi, Terry C Burns, Ashraf M Elyamany, Marc-Eric Halatsch

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma.
Marc-Eric Halatsch, Annika Dwucet, Carl Julius Schmidt, Julius Mühlnickel, Tim Heiland

Pharmaceuticals (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Animal Cancers teach us about Human Biology.
Patricia Kattner, Katharina Zeiler, Verena J Herbener, Katia La Ferla-Brühl, Rebecca Kassubek, Marc-Eric Halatsch

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic Therapy Combined with Bcl-2/Bcl-xL Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9X and Synergistically Enhances Apoptosis in Glioblastoma.
Carolin Golla, Mayas Bilal, Annika Dwucet, Nicolas Bader, Jenson Anthonymuthu, Marc-Eric Halatsch

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Marc-Eric Halatsch, Richard E Kast, Georg Karpel-Massler, Benjamin Mayer, Oliver Zolk

Neurooncol Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.
Richard E Kast, Marc-Eric Halatsch, Rafael Rosell

Cells· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The limitations of targeting MEK signalling in Glioblastoma therapy.
Karthika D Selvasaravanan, Nicole Wiederspohn, Amina Hadzalic, Hannah Strobel, Christel Payer, Marc-Eric Halatsch

Sci Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma.
Maximilian Pruss, Annika Dwucet, Mine Tanriover, Michal Hlavac, Richard Eric Kast, Marc-Eric Halatsch

Br J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Case of Sporadic Malignant Optic Pathway Glioma in 71-Year-Old Woman.
Tim Heiland, Georg Karpel-Massler, Angelika Scheuerle, Christian-Rainer Wirtz, Marc-Eric Halatsch

World Neurosurg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen.
Richard E Kast, Alex P Michael, Iacopo Sardi, Terry C Burns, Tim Heiland, Marc-Eric Halatsch

Brain Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compare and contrast: pediatric cancer versus adult malignancies.
Patricia Kattner, Hannah Strobel, Nika Khoshnevis, Michael Grunert, Stephan Bartholomae, Marc-Eric Halatsch

Cancer Metastasis Rev· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma.
Marc-Eric Halatsch, Richard Eric Kast, Annika Dwucet, Michal Hlavac, Tim Heiland

Br J Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.
Michal Hlavac, Annika Dwucet, Richard Eric Kast, Jens Engelke, Mike-Andrew Westhoff, Marc-Eric Halatsch

Cell Oncol (Dordr)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells.
Sebastian Hasslacher, Lukas Schneele, Sebastien Stroh, Julia Langhans, Katharina Zeiler, Marc-Eric Halatsch

Int J Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acids.
Kamila Cwiklowska, Mike-Andrew Westhoff, Simon Freisinger, Annika Dwucet, Marc-Eric Halatsch

Oncol Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen.
Richard E Kast, Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Hessling, Marc-Eric Halatsch

Brain Sci· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Cervical Medial Branch Blocks In Patients with Cervicogenic Vertigo.
Tim Hahn, Marc-Eric Halatsch, Christian Wirtz, Stephan Klessinger

Pain Physician· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
Melanie Mettang, Viola Meyer-Pannwitt, Georg Karpel-Massler, Shaoxia Zhou, Neil O Carragher, Marc-Eric Halatsch

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis